Lixivaptan
- Generic Name
- Lixivaptan
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H21ClFN3O2
- CAS Number
- 168079-32-1
- Unique Ingredient Identifier
- 8F5X4B082E
- Indication
Investigated for use/treatment in hyponatremia and congestive heart failure.
- Associated Conditions
- -
- Associated Therapies
- -
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- CardioKine Inc.
- Target Recruit Count
- 652
- Registration Number
- NCT00578695
- Locations
- 🇵🇱
Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Sieradz, Poland
🇮🇳Shree Saibaba Heart Institute and Research Centre, Shalimar, Nashik, India
🇵🇱Research Site 2, Krakow, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath